North China Pharmaceutical Company.Ltd (SHA:600812)
China
· Delayed Price · Currency is CNY 6.09
+0.01 (0.16%)
May 21, 2025, 2:45 PM CST
SHA:600812 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1,996 | 1,660 | 988.28 | 1,683 | 5,305 | 4,908 | Upgrade
|
| Cash & Short-Term Investments | 1,996 | 1,660 | 988.28 | 1,683 | 5,305 | 4,908 | Upgrade
|
| Cash Growth | 129.53% | 68.00% | -41.27% | -68.28% | 8.10% | 268.76% | Upgrade
|
| Accounts Receivable | 2,563 | 2,292 | 2,066 | 2,426 | 2,046 | 1,831 | Upgrade
|
| Other Receivables | 1,497 | 1,499 | 1,953 | 1,934 | 2,620 | 2,603 | Upgrade
|
| Receivables | 4,060 | 3,791 | 4,019 | 4,360 | 4,667 | 4,435 | Upgrade
|
| Inventory | 2,395 | 2,511 | 2,608 | 2,523 | 2,392 | 2,453 | Upgrade
|
| Other Current Assets | 343.19 | 297.44 | 402.34 | 416.92 | 348.74 | 316.19 | Upgrade
|
| Total Current Assets | 8,795 | 8,259 | 8,018 | 8,983 | 12,712 | 12,111 | Upgrade
|
| Property, Plant & Equipment | 7,147 | 7,203 | 7,473 | 7,869 | 8,251 | 8,503 | Upgrade
|
| Long-Term Investments | 1,212 | 1,205 | 1,220 | 917.98 | 875.9 | 599.42 | Upgrade
|
| Goodwill | - | - | 3.34 | 3.34 | 3.34 | 3.34 | Upgrade
|
| Other Intangible Assets | 2,714 | 2,756 | 1,975 | 1,650 | 1,344 | 1,237 | Upgrade
|
| Long-Term Deferred Tax Assets | 72.43 | 72.43 | 52.11 | 50.27 | 45.03 | 43.55 | Upgrade
|
| Long-Term Deferred Charges | 2,054 | 1,918 | 2,157 | 1,688 | 1,639 | 1,434 | Upgrade
|
| Other Long-Term Assets | - | 58.55 | 58.55 | 58.7 | 58.83 | - | Upgrade
|
| Total Assets | 21,994 | 21,471 | 20,957 | 21,221 | 24,930 | 23,932 | Upgrade
|
| Accounts Payable | 2,619 | 2,295 | 2,490 | 2,783 | 2,891 | 2,600 | Upgrade
|
| Accrued Expenses | 188.25 | 202.93 | 200.38 | 238.11 | 299.84 | 265.4 | Upgrade
|
| Short-Term Debt | 7,522 | 7,095 | 5,468 | 5,276 | 7,627 | 6,826 | Upgrade
|
| Current Portion of Long-Term Debt | 1,005 | 448.19 | 1,037 | 2,930 | 2,323 | - | Upgrade
|
| Current Portion of Leases | - | 184.3 | 262.95 | 300.15 | 199.12 | - | Upgrade
|
| Current Income Taxes Payable | 62.56 | 16.02 | 34.58 | 46.42 | 37.27 | 29.61 | Upgrade
|
| Current Unearned Revenue | 205.23 | 281.75 | 313.25 | 295.87 | 257.75 | 268.58 | Upgrade
|
| Other Current Liabilities | 424.22 | 438.25 | 462.89 | 540.12 | 604.85 | 1,764 | Upgrade
|
| Total Current Liabilities | 12,026 | 10,962 | 10,269 | 12,409 | 14,240 | 11,753 | Upgrade
|
| Long-Term Debt | 2,858 | 3,459 | 4,081 | 2,129 | 3,301 | 4,618 | Upgrade
|
| Long-Term Leases | 246.18 | 263.53 | 299.16 | 413.39 | 326.74 | - | Upgrade
|
| Long-Term Unearned Revenue | 73.23 | 74.02 | 36.81 | 40.06 | 44.44 | 48.57 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 29.1 | 29.1 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 9.74 | 9.74 | 0.9 | 0.9 | 0.9 | 456.42 | Upgrade
|
| Total Liabilities | 15,242 | 14,797 | 14,686 | 14,993 | 17,913 | 16,876 | Upgrade
|
| Common Stock | 1,716 | 1,716 | 1,716 | 1,716 | 1,716 | 1,631 | Upgrade
|
| Additional Paid-In Capital | 3,862 | 3,862 | 3,899 | 3,886 | 3,886 | 3,978 | Upgrade
|
| Retained Earnings | -139.28 | -196.77 | -306.61 | -311.5 | 480.68 | 510.19 | Upgrade
|
| Comprehensive Income & Other | 8.86 | 8.26 | 7.04 | 9.5 | 2.94 | 5.77 | Upgrade
|
| Total Common Equity | 5,448 | 5,389 | 5,315 | 5,300 | 6,085 | 6,124 | Upgrade
|
| Minority Interest | 1,304 | 1,285 | 955.11 | 928.25 | 931.75 | 931.24 | Upgrade
|
| Shareholders' Equity | 6,752 | 6,675 | 6,270 | 6,228 | 7,017 | 7,056 | Upgrade
|
| Total Liabilities & Equity | 21,994 | 21,471 | 20,957 | 21,221 | 24,930 | 23,932 | Upgrade
|
| Total Debt | 11,631 | 11,450 | 11,148 | 11,049 | 13,777 | 11,443 | Upgrade
|
| Net Cash (Debt) | -9,635 | -9,790 | -10,159 | -9,366 | -8,472 | -6,536 | Upgrade
|
| Net Cash Per Share | -5.58 | -5.70 | -6.23 | -5.46 | -4.98 | -4.03 | Upgrade
|
| Filing Date Shares Outstanding | 1,716 | 1,716 | 1,716 | 1,716 | 1,716 | 1,716 | Upgrade
|
| Total Common Shares Outstanding | 1,716 | 1,716 | 1,716 | 1,716 | 1,716 | 1,631 | Upgrade
|
| Working Capital | -3,231 | -2,702 | -2,251 | -3,426 | -1,528 | 357.96 | Upgrade
|
| Book Value Per Share | 3.18 | 3.14 | 3.10 | 3.09 | 3.55 | 3.76 | Upgrade
|
| Tangible Book Value | 2,734 | 2,633 | 3,337 | 3,646 | 4,738 | 4,884 | Upgrade
|
| Tangible Book Value Per Share | 1.59 | 1.53 | 1.95 | 2.13 | 2.76 | 2.99 | Upgrade
|
| Buildings | - | 4,405 | 4,357 | 4,282 | 4,011 | - | Upgrade
|
| Machinery | - | 7,549 | 6,804 | 6,744 | 6,416 | - | Upgrade
|
| Construction In Progress | - | 381.14 | 162.35 | 154.67 | 672.47 | - | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.